📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Dezima Pharma

1.1 - Company Overview

Dezima Pharma Logo

Dezima Pharma

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of protein-based compounds for the treatment of cardiovascular disease related to dyslipidemia; founded in 2012 and based in Naarden, the Netherlands.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Dezima Pharma

CardioMech Logo

CardioMech

HQ: Norway Website
  • Description: Provider of transcatheter devices for structural heart disease, offering an alternative to cardiac surgery for mitral valve chordal repair. Its catheter-based therapy places artificial chords to reduce or eliminate mitral regurgitation without open-heart surgery, giving surgeons new therapeutic options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CardioMech company profile →
Bolt Medical Logo

Bolt Medical

HQ: United States Website
  • Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bolt Medical company profile →
Retia Medical Logo

Retia Medical

HQ: United States Website
  • Description: Provider of patient monitoring software and hardware, notably the Argos Cardiac Output Monitor using a proprietary Multi-Beat Analysis algorithm for accurate, real-time cardiac output and comprehensive hemodynamic data. Offers quick setup via a single reusable cable, compatibility with arterial lines and multi-parameter monitors, integration with 40+ EMRs, and demonstrated reductions in complications and ICU stay.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Retia Medical company profile →
Cardiokine Logo

Cardiokine

HQ: United States Website
  • Description: Provider of specialty pharmaceutical development for the prevention and treatment of cardiovascular diseases, including lixivaptan, an orally active vasopressin receptor antagonist for congestive heart failure patients with hyponatremia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardiokine company profile →
ViOptix Logo

ViOptix

HQ: United States Website
  • Description: Provider of innovative proprietary tissue oximetry solutions measuring oxygen saturation levels in tissues, including near infrared generators and single-use disposable sensors, plus systems: T.Ox for real-time, non-invasive monitoring following surgery; T.Ox Remote for Wi-Fi access to oxygenation data; and Intra.Ox for handheld perfusion assessments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ViOptix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Dezima Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Dezima Pharma

2.2 - Growth funds investing in similar companies to Dezima Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Dezima Pharma

4.2 - Public trading comparable groups for Dezima Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Dezima Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Dezima Pharma

What does Dezima Pharma do?

Dezima Pharma is a provider of protein-based compounds for the treatment of cardiovascular disease related to dyslipidemia; founded in 2012 and based in Naarden, the Netherlands.

Who are Dezima Pharma's competitors?

Dezima Pharma's competitors and similar companies include CardioMech, Bolt Medical, Retia Medical, Cardiokine, and ViOptix.

Where is Dezima Pharma headquartered?

Dezima Pharma is headquartered in The Netherlands.

How many employees does Dezima Pharma have?

Dezima Pharma has 1,000 employees 🔒.

When was Dezima Pharma founded?

Dezima Pharma was founded in 2010 🔒.

What sector and industry vertical is Dezima Pharma in?

Dezima Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Dezima Pharma

Who are the top strategic acquirers in Dezima Pharma's sector and industry

Top strategic M&A buyers and acquirers in Dezima Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Dezima Pharma?

Top strategic M&A buyers groups and sectors for Dezima Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Dezima Pharma's sector and industry vertical

Which are the top PE firms investing in Dezima Pharma's sector and industry vertical?

Top PE firms investing in Dezima Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Dezima Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Dezima Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Dezima Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Dezima Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Dezima Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Dezima Pharma?

The key public trading comparables and valuation benchmarks for Dezima Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Dezima Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Dezima Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Dezima Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Dezima Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Dezima Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Dezima Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Dezima Pharma